Monoclonal Antibodies: Targeted Therapy
Monoclonal Antibodies (MABs) are a type of targeted medicine remedy. These medicines honor and find specific proteins on cancer cells. There are numerous different MABs to treat cancer. They work in different ways to kill the cancer cell or stop it from growing. Monoclonal antibody remedy is a form of targeted treatment that uses lab-created antibodies that find and kill specific cancer cells. Physicians who treat cancer (oncologists) also use monoclonal antibody remedy to boost the vulnerable system’s capability to defend against cancer. Providers can use this treatment on its own or with other treatments.
Related Conference of Monoclonal Antibodies: Targeted Therapy
December 21-22, 2026
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Paris, France
March 15-16, 2027
22nd International Conference on Allergic Diseases and Clinical Immunology
Paris, France
March 22-23, 2027
14th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Monoclonal Antibodies: Targeted Therapy Conference Speakers
Recommended Sessions
- Allergy & Therapies
- Clinical Immunology & Current & Future Research
- Cytokine based immunotherapy
- Eco Immunology & Behavioural Immunity
- Immune Disorders
- Immunity biological process
- Immuno-Dermatology
- Immuno-Genetics
- Immunoinformatics & Systems Immunology
- Immunology
- Immunomodulators & their side effects
- Molecular Immunology
- Monoclonal Antibodies: Targeted Therapy
- Mucosal Immunology
- Neonatal & Pediatric Immunology
- NeuroImmunology
- Regenerative Immunity
- Reproductive Immunology
- Role of nanomedicine in Immunotherapieutics
- T & B Cell Biology
- Transplant Immunology
- Tumor Immunology
- Infections & Disease
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)

